Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer

Jing Zou1, Fuqiang Yin2, Qi Wang1

  • 1Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University Nanning 530021, Guangxi, P.R. China.

International Journal of Clinical and Experimental Pathology
|August 12, 2015
PubMed

Insights

This study identified nine microRNAs and 38 genes linked to ovarian cancer drug resistance. MicroRNA-141, EPHA7, and PI15 were found to potentially work together in regulating drug resistance, offering new therapeutic targets.

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • Ovarian cancer drug resistance poses a significant clinical challenge.
  • Identifying molecular mechanisms underlying drug resistance is crucial for developing effective treatments.

Purpose of the Study:

  • To identify microRNAs and genes associated with drug resistance in ovarian cancer using microarray data.
  • To investigate the regulatory relationships between identified microRNAs and genes.
  • To explore potential therapeutic targets for overcoming drug resistance.

Main Methods:

  • Downloaded and analyzed microarray datasets (GS54665, GSE33482, GSE28646, GSE15372) from the Gene Expression Omnibus database.
  • Screened dysregulated microRNAs and genes using GEO2R and validated findings with real-time quantitative PCR (qRT-PCR) in ovarian cancer cell lines (SKOV3/DDP, A2780/DDP).
  • Performed comprehensive bioinformatic analyses, including pathway enrichment and microRNA-mRNA interaction analysis.

Main Results:

  • Identified nine differentially expressed microRNAs and 38 genes in drug-resistant ovarian cancer cells.
  • Seven genes (NHSL1, EPHA3, USP51, ZSCAN4, EPHA7, SNCA, PI15) showed consistent expression trends across multiple datasets.
  • Found a negative correlation between microRNA-141 and EPHA7/PI15, suggesting a targeted regulatory relationship.

Conclusions:

  • MicroRNA-141, EPHA7, and PI15 may jointly regulate drug resistance in ovarian cancer.
  • These molecules represent potential targets for novel therapeutic strategies against drug-resistant ovarian cancer.
Keywords:
Ovarian cancerbioinformaticsdrug resistanceexpression profiling microarraygenemicroRNA

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K